{"id":7409,"date":"2021-12-16T07:58:30","date_gmt":"2021-12-16T12:58:30","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/bivalirudin-cas-128270-60-0-ar-ett-antikoagulant-for-laboratorieforskning\/"},"modified":"2021-12-16T07:58:30","modified_gmt":"2021-12-16T12:58:30","slug":"bivalirudin-cas-128270-60-0-ar-ett-antikoagulant-for-laboratorieforskning","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/sv\/product\/bivalirudin-cas-128270-60-0-ar-ett-antikoagulant-for-laboratorieforskning\/","title":{"rendered":"Bivalirudin CAS 128270-60-0 \u00e4r ett antikoagulant f\u00f6r laboratorieforskning"},"content":{"rendered":"<h2><strong>Bivalirudin CAS 128270-60-0 \u00e4r ett antikoagulant f\u00f6r laboratorieforskning<\/strong><\/h2>\n<p>Produktnamn: Bivalirudin<br \/>\nSynonymer: Bivalirudin, TFA;BIVALIRUDIN;BIVALIRUDIN TRIFLUOROACETATE;BITTERMELONP.E;Humant bivalirudin;DPHE-PRO-ARG-PRO-GLY-GLY-GLY-GLY-ASN-GLY-ASP PHE-GLU-GLU-LLE-PRO-GLU-GLU-TYR-LEU;Bivalirudinacetat;Bivalirudin BG 8967, Hirulog, Hirulog I<br \/>\nCAS: 128270-60-0<br \/>\nMF: C98H138N24O33:<br \/>\n 2180.29<br \/>\nEINECS: 274-570-6<br \/>\nProduktkategorier: API;proteiner;Peptid<br \/>\nMol Fil: 128270-60-0.mol<\/p>\n<p>Bivalirudin \u00e4r ett slags syntetiska nya antikoagulantia. Det \u00e4r den direkta, specifika och reversibla h\u00e4mmaren av trombin. Det utvecklades ursprungligen av schweiziska Basset (Biogen). Sedan \u00f6verf\u00f6rdes den till United States Medicines Company och godk\u00e4ndes f\u00f6r marknadsf\u00f6ring i USA \u00e5r 2000. Dess antikoagulerande ingrediens \u00e4r ett slags 20 peptider som h\u00e4rr\u00f6r fr\u00e5n hirudin. Bivalirudin kan specifikt binda till det katalytiska st\u00e4llet och anjonbindningsst\u00e4llet f\u00f6r trombin som finns i blodcirkulationen eller trombusbundet trombin, vilket direkt h\u00e4mmar trombinaktiviteten. Och dess roll k\u00e4nnetecknas av kort, reversibel. Tidiga kliniska studier visar att antikoagulationsbehandlingen av bivalirudin \u00e4r bra. Och f\u00f6rekomsten av bl\u00f6dningar \u00e4r l\u00e5g. S\u00e5 dess anv\u00e4ndning \u00e4r s\u00e4krare \u00e4n traditionell heparinterapi. Det anv\u00e4nds fr\u00e4mst f\u00f6r att f\u00f6rebygga angioplastik interventionell behandling av ischemiska komplikationer av instabil angina pectoris f\u00f6re och efter.<\/p>\n<p> <strong>Bivalirudin CAS 128270-60-0 Kemiska egenskaper<\/strong><br \/>\ndensitet 1,52\u00b10,1 g\/cm3(f\u00f6rutsp\u00e5dd)<br \/>\nlagringstemp. -20\u00b0C<br \/>\nform pulver<br \/>\nf\u00e4rg vit till benvit<br \/>\nInChIKey OIRCOABEOLEUMC-GEJPAHFPSA-N<\/p>\n<p> <strong>Anv\u00e4ndning av Bivalirudin CAS 128270-60-0<\/strong><br \/>\nAntikoagulant; antitrombotisk.<\/p>\n<p>Biluvudin \u00e4r ett syntetiskt antikoagulerande l\u00e4kemedel, en 20-peptidanalog av hirudin, som godk\u00e4ndes f\u00f6r marknadsf\u00f6ring i USA 2000. Bivalirudin binder specifikt till det katalytiska st\u00e4llet f\u00f6r trombin och det anjoniska externa bindningsst\u00e4llet direkt h\u00e4mmar aktiviteten av trombin och d\u00e4rigenom inhiberar de reaktioner som katalyseras och induceras av trombin, och dess verkan \u00e4r reversibel. Bivalirudin anv\u00e4nds huvudsakligen som antikoagulant f\u00f6r elektiv perkutan koronar intervention (PCI) hos vuxna.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Produktnamn: Bivalirudin<br \/>\nCAS: 128270-60-0<br \/>\nMF: C98H138N24O33<br \/>\nMW: 2180.29<br \/>\nEINECS: 274-570-6<br \/>\nMol Fil: 128270-60-0mol.<\/p>\n","protected":false},"featured_media":2280,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[],"product_tag":[2400],"class_list":{"0":"post-7409","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_tag-bivalirudin-cas-128270-60-0-is-an-anticoagulant-for-lab-research-sv","7":"desktop-align-left","8":"tablet-align-left","9":"mobile-align-left","11":"first","12":"instock","13":"shipping-taxable","14":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/product\/7409","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/comments?post=7409"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/media\/2280"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/media?parent=7409"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/product_brand?post=7409"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/product_cat?post=7409"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/sv\/wp-json\/wp\/v2\/product_tag?post=7409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}